SPIRONOLACTONE Side Effects

6772953-8 | Blood Potassium Increased, Ill-defined Disorder
on Jun 08, 2010 Female patient from SWEDEN , 56 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: blood potassium increased, ill-defined disorder. Spironolactone dosage: 25 Mg, Unk. During the same period patient was treated with RAMIPRIL (1.25 Mg, Unk) (View Ramipril Review and Ramipril Label ), POTASSIUM CHLORIDE (750 Mg, 2x/day) (View Potassium Chloride Review and Potassium Chloride Label ), DICLOFENAC (Unk) (View Diclofenac Review and Diclofenac Label ).

6769622-7 | Renal Failure Acute
Patient was taking Spironolactone (View Usage). Patient had the following side effects: renal failure acute on May 26, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, weighting 158.7 lb, was diagnosed with hypertension, stress urinary incontinence, vascular dementia and. Spironolactone dosage: 25 Mg;qd. During the same period patient was treated with XIPAMID (10 Mg;qd) (View Xipamid Review and Xipamid Label ), TORSEMIDE (5 Mg, Qd) (View Torsemide Review and Torsemide Label ), RAMIPRIL (2.5mg, Qd) (View Ramipril Review and Ramipril Label ), MICTONORM (PROPIVERINE HYDROCHLORIDE) (View Mictonorm (propiverine Hydrochloride) Review and Mictonorm (propiverine Hydrochloride) Label ), MELPERON (MELPERONE HYDROCHLORIDE) (25 Mg, Qd;) (View Melperon (melperone Hydrochloride) Review and Melperon (melperone Hydrochloride) Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), PANTOPRAZOL 40MG (PANTOPRAZOL) GASTRO RESISTANT TABLET (View Pantoprazol 40mg (pantoprazol) Gastro-resistant Tablet Review and Pantoprazol 40mg (pantoprazol) Gastro-resistant Tablet Label ), CLOPIDOGREL 75MG (CLOPIDOGREL) FILM COATED TABLET (View Clopidogrel 75mg (clopidogrel) Film Coated Tablet Review and Clopidogrel 75mg (clopidogrel) Film Coated Tablet Label ). Patient was hospitalized.

6768621-9 | Abdominal Distension, Abdominal Pain Upper, Blood Potassium Increased, Crying, Dysphagia, Dyspnoea, Faeces Discoloured, Flatulence, Gastrointestinal Hypermotility
Adverse event was reported on Jun 03, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: 50 Mg, 2x/day) was diagnosed with hepatic neoplasm malignant and. Location: UNITED STATES , weighting 105.8 lb, After Spironolactone was administered, patient had the following side effects: abdominal distension, abdominal pain upper, blood potassium increased, crying, dysphagia, dyspnoea, faeces discoloured, flatulence, gastrointestinal hypermotility. During the same period patient was treated with METAMUCIL 2 (Unk) (View Metamucil-2 Review and Metamucil-2 Label ), LASIX (Unk) (View Lasix Review and Lasix Label ).

6765324-1 | Gynaecomastia
on Jun 10, 2010 Male patient from UNITED STATES , 63 years of age, was diagnosed with cardiac failure congestive and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia. Spironolactone dosage: 1 Tab Every Day Po.


6762145-0 | Acute Prerenal Failure, Dehydration, Hypotension, Pleural Effusion, Renal Failure Acute
on May 26, 2010 Female patient from GERMANY , 84 years of age, weighting 158.7 lb, was diagnosed with hypertension, vascular dementia, stress urinary incontinence, extrapyramidal disorder, initial insomnia, prophylaxis against gastrointestinal ulcer and was treated with Spironolactone (View Usage). Patient had the following side effects: acute prerenal failure, dehydration, hypotension, pleural effusion, renal failure acute. Spironolactone dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), MELPERON 25 (View Melperon 25 Review and Melperon 25 Label ), XIPAMID (View Xipamid Review and Xipamid Label ), MICTONORM (View Mictonorm Review and Mictonorm Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6761260-5 | Renal Failure Acute
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: renal failure acute on May 26, 2010 from GERMANY Additional patient health information: Female patient , 59 years of age, weighting 136.7 lb, was diagnosed with renal failure chronic, hypertension, cardiac failure chronic, ischaemic heart disease prophylaxis and. Spironolactone dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6756899-7 | Cardiac Failure
Adverse event was reported on May 24, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: ) . Location: JAPAN , child 8 years of age, weighting 50.71 lb, Patient experienced the following unwanted or unexpected effects: cardiac failure. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6748486-1 | Breast Enlargement, Breast Pain, Chest Pain, Depression, Fatigue, Hypersensitivity, Menstruation Irregular, Microvascular Angina, Muscle Spasms
on May 27, 2010 Female patient from UNITED STATES , 47 years of age, weighting 160.0 lb, was diagnosed with acne (What is acne?) and was treated with Spironolactone (View Usage). Patient had the following side effects: breast enlargement, breast pain, chest pain (What is chest pain?), depression (What is depression?), fatigue, hypersensitivity, menstruation irregular, microvascular angina, muscle spasms. Spironolactone dosage: One Daily Po. Patient was hospitalized.

6743148-9 | Acute Myocardial Infarction, Cardiac Failure, Dehydration, Diarrhoea, Renal Failure Acute, Vascular Insufficiency
on May 11, 2010 Female patient from GERMANY , 59 years of age, was diagnosed with renal failure chronic, hypertension and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: acute myocardial infarction, cardiac failure, dehydration, diarrhoea, renal failure acute, vascular insufficiency. Spironolactone dosage: 50 Mg; Po. During the same period patient was treated with RAMIPRIL (50 Mg; Po) (View Ramipril Review and Ramipril Label ), HYDROCHLOROTHIAZIDE (25 Mg; Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6739895-5 | Abdominal Discomfort, Blood Potassium Increased, Dyspnoea, Faeces Discoloured, Psychomotor Hyperactivity
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal discomfort, blood potassium increased, dyspnoea, faeces discoloured, psychomotor hyperactivity on May 13, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 105.8 lb, was diagnosed with hepatic neoplasm malignant and. Spironolactone dosage: 50 Mg, 2x/day. During the same period patient was treated with METAMUCIL 2 (Unk) (View Metamucil-2 Review and Metamucil-2 Label ), LASIX (Unk) (View Lasix Review and Lasix Label ).

6731068-5 | Renal Failure Acute
Adverse event was reported on May 04, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with renal failure chronic, hypertension, cardiac failure chronic, ischaemic heart disease prophylaxis and. Location: GERMANY , 59 years of age, weighting 136.7 lb, Patient had the following side effects: renal failure acute. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6728533-3 | Hallucination, Hyperkalaemia
on May 03, 2010 Female patient from GERMANY , 89 years of age, weighting 154.3 lb, was diagnosed with hypertension, tachyarrhythmia, sleep disorder (What is sleep disorder?), depression (What is depression?), dyspepsia and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: hallucination, hyperkalaemia. Spironolactone dosage: . During the same period patient was treated with DIGITOXIN (View Digitoxin Review and Digitoxin Label ), RASILEZ /01763601/ (View Rasilez /01763601/ Review and Rasilez /01763601/ Label ), EXFORGE HCT (1 Df Enthalt 10 Mg Amlidipin, 160 Mg Valsartan, 12,5 Mg Hydrochlorothiazid) (View Exforge Hct Review and Exforge Hct Label ), BIKALM (View Bikalm Review and Bikalm Label ), MIRTAZAPINE (View Mirtazapine Review and Mirtazapine Label ), METOPROLOL TARTRATE (Stationar Beloc Zok Gleich 1x1tbl.) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PANTOZOL (View Pantozol Review and Pantozol Label ). Patient was hospitalized.

6719200-0 | Hyperkalaemia
on May 10, 2010 Male patient from UNITED STATES , 66 years of age, weighting 199.1 lb, was diagnosed with liver disorder and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Spironolactone dosage: 50 Mg Bid Po. Patient was hospitalized.

6717278-1 | Hyperkalaemia, Renal Failure
Patient was taking Spironolactone (View Usage). Patient had the following side effects: hyperkalaemia, renal failure on Apr 22, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, was diagnosed with hypertension and. Spironolactone dosage: 50 Mg; Qd; Po. During the same period patient was treated with RAMIPRIL (5 Mg; Qd; Po) (View Ramipril Review and Ramipril Label ), ACTRAPID HUMAN (View Actrapid Human Review and Actrapid Human Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CARMEN (View Carmen Review and Carmen Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), GLUCOBAY (View Glucobay Review and Glucobay Label ), METHIZOL (View Methizol Review and Methizol Label ), NOVOMIX (View Novomix Review and Novomix Label ). Patient was hospitalized.

6713690-5 | Acute Prerenal Failure, Altered State Of Consciousness, Dehydration, Disorientation, Disturbance In Attention, Dry Skin, Erythema, Fall
Adverse event was reported on Apr 28, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: 25 Mg; Po) was diagnosed with hypertension and. Location: European Union , 84 years of age, After Spironolactone was administered, patient had the following side effects: acute prerenal failure, altered state of consciousness, dehydration, disorientation, disturbance in attention, dry skin, erythema, fall (What is fall?). During the same period patient was treated with RAMIPRIL (2.5 Mg; P.o) (View Ramipril Review and Ramipril Label ), XIPAMIDE (View Xipamide Review and Xipamide Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), MELPERONE (View Melperone Review and Melperone Label ), MICTONORM (View Mictonorm Review and Mictonorm Label ), BIPERIDAN (View Biperidan Review and Biperidan Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6712524-2 | Breast Pain, Breast Swelling, Nipple Pain
on May 05, 2010 Male patient from UNITED STATES , 53 years of age, weighting 291.0 lb, was diagnosed with oedema peripheral and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: breast pain, breast swelling, nipple pain. Spironolactone dosage: 1 Tab Daily Every Day Mouth.

6707938-0 | Renal Failure Acute
on Apr 19, 2010 Female patient from GERMANY , 84 years of age, weighting 158.7 lb, was diagnosed with hypertension, vascular dementia, stress urinary incontinence, extrapyramidal disorder, initial insomnia, prophylaxis against gastrointestinal ulcer and was treated with Spironolactone (View Usage). Patient had the following side effects: renal failure acute. Spironolactone dosage: . During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), MELPERON 25 (View Melperon 25 Review and Melperon 25 Label ), XIPAMID (View Xipamid Review and Xipamid Label ), MICTONORM (View Mictonorm Review and Mictonorm Label ), BIPERIDEN HYDROCHLORIDE TAB (View Biperiden Hydrochloride Tab Review and Biperiden Hydrochloride Tab Label ), ZOLPIDEM (View Zolpidem Review and Zolpidem Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ). Patient was hospitalized.

6703275-9 | Renal Failure Acute
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: renal failure acute on Apr 19, 2010 from GERMANY Additional patient health information: Female patient , 84 years of age, weighting 158.7 lb, was diagnosed with hypertension, stress urinary incontinence, vascular dementia, extrapyramidal disorder, initial insomnia, prophylaxis against gastrointestinal ulcer and. Spironolactone dosage: 25 Mg, Qd. During the same period patient was treated with XIPAMID (10 Mg, Qd) (View Xipamid Review and Xipamid Label ), TORSEMIDE (5 Mg, Qd) (View Torsemide Review and Torsemide Label ), RAMIPRIL (2.5 Mg, Qd) (View Ramipril Review and Ramipril Label ), MICTONORM (15 Mg, Qd) (View Mictonorm Review and Mictonorm Label ), MELPERON 25 (25 Mg, Qd) (View Melperon 25 Review and Melperon 25 Label ), AKINETON (2 Mg, Qd) (View Akineton Review and Akineton Label ), ZOLPIDEM AL 5 MG (5 Mg, Qd) (View Zolpidem Al 5 Mg Review and Zolpidem Al 5 Mg Label ), PANTOPRAZOL 40 MG (40 Mg, Qd) (View Pantoprazol 40 Mg Review and Pantoprazol 40 Mg Label ). Patient was hospitalized.

6701104-0 | Hyperkalaemia, Renal Artery Stenosis, Renal Failure Acute
Adverse event was reported on Apr 28, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: 25 Mg Every Day) was diagnosed with cardiac failure congestive and. Location: UNITED STATES , 55 years of age, weighting 207.2 lb, Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal artery stenosis, renal failure acute. During the same period patient was treated with LISINOPRIL (20 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6701093-9 | Blood Creatinine Increased, Blood Urea Increased, Ejection Fraction Decreased, Hyperkalaemia
on Apr 28, 2010 Male patient from UNITED STATES , 86 years of age, weighting 198.4 lb, was diagnosed with cardiac failure congestive and was treated with Spironolactone (View Usage). Patient had the following side effects: blood creatinine increased, blood urea increased, ejection fraction decreased, hyperkalaemia. Spironolactone dosage: 100 Mg Every Day Po. During the same period patient was treated with LISINOPRIL (5 Mg Every Day Po) (View Lisinopril Review and Lisinopril Label ). Patient was hospitalized.

6697797-7 | Neutropenia
on Apr 13, 2010 Male patient from UNITED KINGDOM , 55 years of age, was diagnosed with ascites and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: neutropenia. Spironolactone dosage: 25 Mg;po. During the same period patient was treated with METHADONE HCL (View Methadone Hcl Review and Methadone Hcl Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LACTULOSE (View Lactulose Review and Lactulose Label ).

6686205-8 | Fatigue, Muscle Spasms, Muscle Twitching, Muscular Weakness, Myalgia
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: fatigue, muscle spasms, muscle twitching, muscular weakness, myalgia on Apr 15, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 126.0 lb, was diagnosed with meniere's disease (What is meniere's disease?) and. Spironolactone dosage: 25 Mg Tablet Daily Po.

6668199-4 | Bradycardia, Bundle Branch Block Right, Hyperkalaemia
Adverse event was reported on Apr 05, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: 100 Mg Every Day Po) was diagnosed with cardiac failure congestive, diabetes mellitus and. Location: UNITED STATES , 65 years of age, weighting 253.1 lb, Patient had the following side effects: bradycardia, bundle branch block right, hyperkalaemia. During the same period patient was treated with VALSARTAN (160 Mg Every Day Po) (View Valsartan Review and Valsartan Label ). Patient was hospitalized.

6644760-8 | Blood Pressure Decreased, Hyperkalaemia, Hypophagia, Renal Failure Acute, Ventricular Tachycardia
on Mar 18, 2010 Male patient from UNITED STATES , 69 years of age, was diagnosed with cardiac failure congestive and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: blood pressure decreased, hyperkalaemia, hypophagia, renal failure acute, ventricular tachycardia. Spironolactone dosage: 25 Mg Every Day Po. Patient was hospitalized.

6611980-8 | Gynaecomastia
on Mar 02, 2010 Male patient from UNITED STATES , 69 years of age, weighting 188.3 lb, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia. Spironolactone dosage: Every Day Po.

6600709-5 | Breast Enlargement, Breast Pain
Patient was taking Spironolactone (View Usage). Patient had the following side effects: breast enlargement, breast pain on Feb 23, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, weighting 260.0 lb, was diagnosed with fibromyalgia and. Spironolactone dosage: 50mg Twice Daily Mouth.

6599886-4 | Erysipelas, Hyponatraemia
Adverse event was reported on Feb 01, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: Po) was diagnosed with essential hypertension and. Location: SWEDEN , 67 years of age, After Spironolactone was administered, patient had the following side effects: erysipelas, hyponatraemia. During the same period patient was treated with IMPUGAN (View Impugan Review and Impugan Label ), MOVICOL (View Movicol Review and Movicol Label ), OMEPRAZOL (View Omeprazol Review and Omeprazol Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), FOLACIN (View Folacin Review and Folacin Label ), ALVEDON (View Alvedon Review and Alvedon Label ), BETAPRED (View Betapred Review and Betapred Label ). Patient was hospitalized.

6596520-4 | Hyperkalaemia, Renal Failure Acute
on Feb 22, 2010 Male patient from UNITED STATES , 53 years of age, weighting 303.0 lb, was diagnosed with hypertension and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia, renal failure acute. Spironolactone dosage: 25 Mg Bid Po. During the same period patient was treated with HYDROCHLOROTHIAZIDE (25 Mg Every Day Po) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6585299-8 | Breast Tenderness, Gynaecomastia
on Feb 16, 2010 Male patient from UNITED STATES , 76 years of age, weighting 228.0 lb, was diagnosed with cardiac failure, cardiac failure congestive, renal failure chronic and was treated with Spironolactone (View Usage). Patient had the following side effects: breast tenderness, gynaecomastia. Spironolactone dosage: 25 Mg Bid Po.

6582881-9 | Sclerosing Encapsulating Peritonitis
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: sclerosing encapsulating peritonitis on Feb 02, 2010 from UNITED STATES Additional patient health information: Male patient , 59 years of age, was diagnosed with intestinal obstruction and. Spironolactone dosage: . During the same period patient was treated with NEURONTIN (View Neurontin Review and Neurontin Label ), INSULIN (View Insulin Review and Insulin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SERTRALINE HCL (View Sertraline Hcl Review and Sertraline Hcl Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ANTIEMETICS AND ANTINAUSEANTS (View Antiemetics And Antinauseants Review and Antiemetics And Antinauseants Label ). Patient was hospitalized.

6582758-9 | Cardiac Failure Congestive, Cardiomegaly, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus Inadequate Control, Dyspnoea, Fall, Hypotension, Lower Respiratory Tract Infection, Malaise
Adverse event was reported on Feb 04, 2010 by a Male patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with cardiac failure congestive, schizophrenia and. Location: UNITED KINGDOM , 65 years of age, Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, cardiomegaly, chronic obstructive pulmonary disease, diabetes mellitus inadequate control, dyspnoea, fall (What is fall?), hypotension, lower respiratory tract infection, malaise. During the same period patient was treated with CLOZARIL (Unk) (View Clozaril Review and Clozaril Label ), STELAZINE (View Stelazine Review and Stelazine Label ). Patient was hospitalized.

6578857-8 | Primary Hypogonadism
on Jan 29, 2010 Male patient from GERMANY , 39 years of age, weighting 180.8 lb, was diagnosed with liver disorder, hypertension and was treated with Spironolactone (View Usage). Patient had the following side effects: primary hypogonadism. Spironolactone dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6566295-3 | Acute Prerenal Failure, Lactic Acidosis
on Jan 21, 2010 Male patient from GERMANY , 61 years of age, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: acute prerenal failure, lactic acidosis. Spironolactone dosage: 25 Mg, 1x/day. During the same period patient was treated with OLMETEC (Unk) (View Olmetec Review and Olmetec Label ), DIURAPID (40 Mg, 1x/day) (View Diurapid Review and Diurapid Label ), ENALAPRIL MALEATE (Unk) (View Enalapril Maleate Review and Enalapril Maleate Label ), MEGLUCON (Unk) (View Meglucon Review and Meglucon Label ). Patient was hospitalized.

6552839-4 | Atrial Fibrillation, Bradycardia, Dyspnoea Exertional, Fatigue, Haemodialysis, Heart Rate Irregular, Hyperkalaemia, Hypertension, Metabolic Acidosis
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: atrial fibrillation (What is atrial fibrillation?), bradycardia, dyspnoea exertional, fatigue, haemodialysis, heart rate irregular, hyperkalaemia, hypertension, metabolic acidosis on Jan 07, 2010 from SWITZERLAND Additional patient health information: Female patient , 76 years of age, weighting 190.9 lb, was diagnosed with hypertension and. Spironolactone dosage: 25 Mg; Qd;. During the same period patient was treated with RASILEZ (View Rasilez Review and Rasilez Label ), IRBESARTAN HYDROCHLOROTHIAZIDE (View Irbesartan - Hydrochlorothiazide Review and Irbesartan - Hydrochlorothiazide Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6552013-1 | Blood Creatinine Increased, Hyperkalaemia
Adverse event was reported on Jan 11, 2010 by a Female patient taking Spironolactone (View Usage) (Dosage: ) . Location: UNITED KINGDOM , 72 years of age, Patient had the following side effects: blood creatinine increased, hyperkalaemia. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), BENDROFLUMETHIAZIDE (View Bendroflumethiazide Review and Bendroflumethiazide Label ), DOXAZOSIN MESYLATE (View Doxazosin Mesylate Review and Doxazosin Mesylate Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.

6539711-0 | Cardiac Arrest, Respiratory Arrest
on Jan 04, 2010 Female patient from UNITED STATES , 34 years of age, was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), respiratory arrest. Spironolactone dosage: . During the same period patient was treated with MORPHINE (View Morphine Review and Morphine Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ).

6531656-5 | Hyperkalaemia
on Jan 07, 2010 Male patient from UNITED STATES , 56 years of age, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: hyperkalaemia. Spironolactone dosage: . Patient was hospitalized.

6531606-1 | Gynaecomastia
Patient was taking Spironolactone (View Usage). Patient had the following side effects: gynaecomastia on Jan 07, 2010 from UNITED STATES Additional patient health information: Male patient , 62 years of age, . Spironolactone dosage: 100 Mg Every Day Po. Patient was hospitalized.

6525946-X | Bradycardia, Dizziness, Haemodialysis, Hypotension, Renal Failure Acute, Vomiting
Adverse event was reported on Dec 08, 2009 by a Male patient taking Spironolactone (View Usage) (Dosage: 100 Mg; Bid; Po) was diagnosed with cirrhosis alcoholic, hypertension and. Location: GERMANY , 71 years of age, After Spironolactone was administered, patient had the following side effects: bradycardia, dizziness (What is dizziness?), haemodialysis, hypotension, renal failure acute, vomiting. During the same period patient was treated with RAMIPRIL (5 Mg; Qd; Po) (View Ramipril Review and Ramipril Label ), PROPRANOLOL (12.5 Mg; Qd; Po) (View Propranolol Review and Propranolol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), OMEP (View Omep Review and Omep Label ). Patient was hospitalized.

6522992-7 | Deep Vein Thrombosis, Dizziness, Gynaecomastia, Heart Rate Increased, Pulmonary Embolism
on Dec 08, 2009 Male patient from UNITED KINGDOM , 42 years of age, was diagnosed with feminisation acquired and was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: deep vein thrombosis (What is deep vein thrombosis?), dizziness (What is dizziness?), gynaecomastia, heart rate increased, pulmonary embolism (What is pulmonary embolism?). Spironolactone dosage: 200 Mg; Qd; Po. During the same period patient was treated with ESTRADIOL (View Estradiol Review and Estradiol Label ), ETHINYL ESTRADIOL (View Ethinyl Estradiol Review and Ethinyl Estradiol Label ). Patient was hospitalized.

6516089-X | Atrial Fibrillation, Back Pain, Dehydration, Dyspepsia, Fear Of Eating, Gastrooesophageal Reflux Disease, Hypertension, Nausea, Oedema
on Nov 20, 2009 Female patient from UNITED KINGDOM , 43 years of age, weighting 359.4 lb, was diagnosed with obesity (What is obesity?), cardiac disorder and was treated with Spironolactone (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), dehydration, dyspepsia, fear of eating, gastrooesophageal reflux disease, hypertension, nausea (What is nausea?), oedema. Spironolactone dosage: 50 Mg, Unk. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ACOMPLIA (View Acomplia Review and Acomplia Label ), ASPIRIN (5 Mg, Unk) (View Aspirin Review and Aspirin Label ), ATENOLOL (50 Mg, 1x/day) (View Atenolol Review and Atenolol Label ), ATORVASTATIN (80 Mg, 1x/day) (View Atorvastatin Review and Atorvastatin Label ), CODEINE (120 Mg, Unk) (View Codeine Review and Codeine Label ), FUROSEMIDE (40 Mg, 1x/day) (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

6505595-X | Ovarian Cyst
Patient was taking Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: ovarian cyst (What is ovarian cyst?) on Dec 07, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 1.54 lb, . Spironolactone dosage: 4 Unk, Unk. During the same period patient was treated with HYDROCHLOROTHIAZIDE (Unk) (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ).

6505515-8 | Hypotension
Adverse event was reported on Dec 04, 2009 by a Male patient taking Spironolactone (View Usage) (Dosage: ) was diagnosed with cardiac failure chronic, hypertension, depression (What is depression?), spinal disorder, type 2 diabetes mellitus, chronic obstructive pulmonary disease, hypothyroidism and. Location: GERMANY , 67 years of age, Patient experienced the following unwanted or unexpected effects: hypotension. During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), THIAMAZOLE (View Thiamazole Review and Thiamazole Label ). Patient was hospitalized.

6504979-3 | Hypotension
on Dec 04, 2009 Male patient from GERMANY , 67 years of age, was diagnosed with cardiac failure chronic, hypertension, depression (What is depression?), spinal disorder, type 2 diabetes mellitus, chronic obstructive pulmonary disease, hypothyroidism and was treated with Spironolactone (View Usage). Patient had the following side effects: hypotension. Spironolactone dosage: . During the same period patient was treated with DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), CYMBALTA (View Cymbalta Review and Cymbalta Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), CELEBREX (View Celebrex Review and Celebrex Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), THIAMAZOLE (View Thiamazole Review and Thiamazole Label ). Patient was hospitalized.

6501966-6 | Lactic Acidosis, Renal Failure Acute
on Dec 02, 2009 Male patient from GERMANY , 61 years of age, weighting 198.4 lb, was diagnosed with hypertension, type 2 diabetes mellitus and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: lactic acidosis, renal failure acute. Spironolactone dosage: . During the same period patient was treated with DIURAPID (View Diurapid Review and Diurapid Label ), OLMETEC (View Olmetec Review and Olmetec Label ), ENAHEXAL COMP. (1 Df= 5mg Enalapril + 12.5mg Hct) (View Enahexal Comp. Review and Enahexal Comp. Label ), MEGLUCON (View Meglucon Review and Meglucon Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), HUMALOG (Dosis Je Applikation: 20/0/16 Iu) (View Humalog Review and Humalog Label ). Patient was hospitalized.

6488818-5 | Bile Duct Cancer
Patient was taking Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: bile duct cancer on Dec 01, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 70 years of age, weighting 143.3 lb, was diagnosed with left ventricular failure and. Spironolactone dosage: . During the same period patient was treated with BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ).

6468096-3 | Arrhythmia, Bradycardia, Dizziness, Haemodialysis, Hyperkalaemia, Renal Failure Acute, Vomiting
Adverse event was reported on Nov 13, 2009 by a Male patient taking Spironolactone (View Usage) (Dosage: 100 Mg Bid; Po) was diagnosed with cirrhosis alcoholic, hypertension and. Location: GERMANY , 71 years of age, Patient had the following side effects: arrhythmia (What is arrhythmia?), bradycardia, dizziness (What is dizziness?), haemodialysis, hyperkalaemia, renal failure acute, vomiting. During the same period patient was treated with RAMIPRIL (5 Mg, Qd, Po) (View Ramipril Review and Ramipril Label ), PROPRANOLOL HCL EXTENDED RELEASE CAPSULES USP, 60MG (AELLC) (PROPRANOL (12.5 Mg, Qd, Po) (View Propranolol Hcl Extended-release Capsules Usp, 60mg (aellc) (propranol Review and Propranolol Hcl Extended-release Capsules Usp, 60mg (aellc) (propranol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), OMEP (View Omep Review and Omep Label ). Patient was hospitalized.

6468096-3 | Arrhythmia, Bradycardia, Dizziness, Haemodialysis, Hyperkalaemia, Renal Failure Acute, Vomiting
on Nov 13, 2009 Male patient from GERMANY , 71 years of age, was diagnosed with cirrhosis alcoholic, hypertension and was treated with Spironolactone (View Usage). After Spironolactone was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), bradycardia, dizziness (What is dizziness?), haemodialysis, hyperkalaemia, renal failure acute, vomiting. Spironolactone dosage: 100 Mg Bid; Po. During the same period patient was treated with RAMIPRIL (5 Mg, Qd, Po) (View Ramipril Review and Ramipril Label ), PROPRANOLOL HYDROCHLORIDE (12.5 Mg, Qd, Po) (View Propranolol Hydrochloride Review and Propranolol Hydrochloride Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ). Patient was hospitalized.

6466909-2 | Altered State Of Consciousness, Hypoglycaemia, Renal Impairment
on Nov 18, 2009 Female patient from JAPAN , 83 years of age, weighting 101.4 lb, was treated with Spironolactone (View Usage). Patient experienced the following unwanted or unexpected effects: altered state of consciousness, hypoglycaemia, renal impairment. Spironolactone dosage: 25 Mg,daily. During the same period patient was treated with CIBENZOLINE SUCCINATE (200 Mg, Daily) (View Cibenzoline Succinate Review and Cibenzoline Succinate Label ), FUROSEMIDE (40 Mg, Daily) (View Furosemide Review and Furosemide Label ), FAMOTIDINE (20 Mg, Unk) (View Famotidine Review and Famotidine Label ), METILDIGOXIN (0.5 Mg, Unk) (View Metildigoxin Review and Metildigoxin Label ), ALLOPURINOL (100 Mg, Unk) (View Allopurinol Review and Allopurinol Label ), REBAMIPIDE (300 Mg, Unk) (View Rebamipide Review and Rebamipide Label ), WARFARIN SODIUM (2 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ). Patient was hospitalized.

6465492-5 | Atrial Fibrillation, Back Pain, Dehydration, Dyspepsia, Fear Of Eating, Flank Pain, Gastrooesophageal Reflux Disease, Haemorrhoids, Hypertension
Patient was taking Spironolactone (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), back pain (What is back pain?), dehydration, dyspepsia, fear of eating, flank pain, gastrooesophageal reflux disease, haemorrhoids, hypertension on Nov 10, 2009 from UNITED KINGDOM Additional patient health information: Female patient , 43 years of age, . Spironolactone dosage: 50 Mg; Po. During the same period patient was treated with LISINOPRIL (View Lisinopril Review and Lisinopril Label ), RIMONABANT (View Rimonabant Review and Rimonabant Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ISOSORBIDE MONONITRATE (View Isosorbide Mononitrate Review and Isosorbide Mononitrate Label ), ISPAGHULA HUSK (View Ispaghula Husk Review and Ispaghula Husk Label ). Patient was hospitalized.